US10590130B2: camizestrant cross-references 65 other patent(s) via PubChem structural search (6 likely-same-scaffold hit(s))

Real cross-patent screening for US10590130B2 (AstraZeneca AB, 'Chemical compounds'). Target compound camizestrant resolved to canonical SMILES and screened against PubChem's patent-compound index. Result: 65 unique other patents reference structurally near-identical (6 hits) or related-scaffold (6 hits) compounds. Search completed in 21.0s. Structural overlap only; no infringement conclusion stated.